Lycia Therapeutics is a Biotech company based in South San Francisco, CA. It has raised $232M in total funding. Latest round: Series D.
Lycia Therapeutics is a Biotech company based in South San Francisco, CA. Lycia Therapeutics has raised $232M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series D announced in July 2025. The round record for Lycia Therapeutics runs through 2025; nothing later has been disclosed. Investors on record include Venrock Healthcare Capital Partners, Janus Henderson Investors, Marshall Wace, Franklin Templeton, Redmile Group, RTW Investments and 4 others. 10 distinct backers are named across the disclosed rounds.
We update the Lycia Therapeutics record whenever a new round is filed or announced, so the totals above track the public record rather than estimates. Related Biotech companies in South San Francisco and their backers are listed below.
Company funding database · Investor directory · Founder database · Mega-rounds 2026